Effect of 12 Weeks of Resistive Exercises Versus Aerobic Exercises in Overweight Hypertensive Postmenopausal Women

Overview

Sixty postmenopausal women participated in this study from gynecological outpatient clinic, at Al-Zahra universal Hospital, Al Azhar University, and Cairo. They were first diagnosed to be hypertensive in their early postmenopausal period .Their blood pressure ranged between 140/90mmHg to 170/105mmHg, their ages ranged from 50 to 60 years and their body mass index ranged from 30:35 kg/m2.

Full Title of Study: “Exercise and Menopausal Hypertension”

Study Type

• Study Type: Interventional
• Study Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Primary Purpose: Treatment
  • Masking: Double (Investigator, Outcomes Assessor)
• Study Primary Completion Date: July 30, 2018

Detailed Description

The participants were divided randomly according to closed envelop into three equal groups in number: Group A (RE) consisted of twenty women who participated in the resistive exercise program. Group B (AE) group: consisted of twenty women who participated in an aerobic exercise program. All patients in both groups (A & B) participated in the exercises three times per week for twelve weeks and every session lasted for 45 min and continues their antihypertensive medication

Interventions

• Device: resistive exercise
  • resistive exercise by elastic band for 12 weeks
• Device: aerobic exercise in form of treadmill walking
  • aerobic exercise in form of treadmill walking for 12 weeks

Arms, Groups and Cohorts

• Experimental: resistive exercise
  • resistive exercises using elastic band(Thera Band) Sets were at moderate intensity, 8-10 repetitions for every motion for 12 weeks
• Experimental: Aerobic exercise
  • Aerobic exercise in form of treadmill walking for 45 minutes for 12 weeks

Clinical Trial Outcome Measures

Primary Measures

• Assessment of changes in the systolic blood pressure
  • Time Frame: 12 weeks
  • using the mercury column sphygmomanometer

Secondary Measures

• Assessment of changes in the diastolic blood pressure
  • Time Frame: 12 weeks
  • using the mercury column sphygmomanometer

Participating in This Clinical Trial

Inclusion Criteria

• All women diagnosed as essential hypertension. – All women must be in their early postmenopausal period Exclusion Criteria:

• Lesion to higher centers leading to hypertension (embolism) – any cardiovascular disease – premature menopause – surgical menopause – severe hypertension – diabetic – under treatment of hormonal therapy.

Gender Eligibility: Female

Minimum Age: 50 Years

Maximum Age: 60 Years

Are Healthy Volunteers Accepted: No

Investigator Details

• Lead Sponsor
  • Cairo University
• Provider of Information About this Clinical Study
  • Principal Investigator: Ghada Ebrahim El Refaye, Assistant Professor of physical therapy for women’s health – Cairo University
• Overall Official(s)
  • ghada E elrefaye, Professor, Principal Investigator, Assistant professor of physical therapy for women’s health